News - Truvada, Genetics

Filter

Current filters:

TruvadaGenetics

Popular Filters

1 to 25 of 39 results

Oxford Gene Technology acquires Cytocell to expand genomics offering

Oxford Gene Technology acquires Cytocell to expand genomics offering

04-03-2014

Genetic research company Oxford Gene Technology has acquired Cambridge-based Cytocell, a leading provider…

BiotechnologyGeneticsMergers & AcquisitionsOxford Gene TechnologyUK

AHF claims victory over FDA on Gilead’s PrEP

19-02-2014

The USA-based AIDS Healthcare Foundation (AHF) says it has won another key legal victory late last week…

Anti-viralsBiotechnologyGilead SciencesLegalNorth AmericaRegulationTruvadaUSA

NicOx appoints financial partner to assess Duchenne Muscular Dystrophy treatment

14-02-2014

French biotechnology firm NicOx (Euronext Paris: COX) has granted an undisclosed financial partner an…

BiotechnologyFranceGeneticsLicensingnaproxcinodNicOx

Ipsen’s Dysport next generation shows safety and efficacy in Phase III

Ipsen’s Dysport next generation shows safety and efficacy in Phase III

05-02-2014

French drugmaker Ipsen today announced the results of the international Phase III clinical trial of Dysport…

DysportFranceGeneticsIpsenPharmaceuticalResearch

Mylan gets exclusive rights to distribute Gilead branded drugs in India

Mylan gets exclusive rights to distribute Gilead branded drugs in India

31-01-2014

US generics major Mylan says its India-based subsidiary has been named) exclusive branded medicines business…

AmbisomeAnti-viralsAsia-PacificBiotechnologyGilead SciencesIndiaMarkets & MarketingMylan LaboratoriesStribildTruvadaViread

UCB launches online search for rare phenotypes

UCB launches online search for rare phenotypes

28-01-2014

Belgian drugmaker UCB (Euronext Brussels: UCB) has launched an online search to find rare phenotypes…

GeneticsGlobalPharmaceuticalRare diseasesResearchUCB

Nuevolution signs licensing agreement with Novartis

Nuevolution signs licensing agreement with Novartis

10-01-2014

Denmark-based Nuevolution has entered into a non-exclusive technology licensing agreement with Swiss…

BiotechnologyDenmarkGeneticsLicensingNorthern EuropeNovartisNuevolutionResearch

Scotland demonstrates its collaborative approach to cell therapy development

Scotland demonstrates its collaborative approach to cell therapy development

14-10-2013

Scottish stem cell companies Sistemic and Roslin Cells say they are working together with c to make the…

BiotechnologyEuropeGeneticsResearchRoslin CellsSistemic

arGEN-X R&D milestone triggers payment from Shire

19-09-2013

Belgium-based preclinical stage biotech firm arGEN-X has announced a key milestone in its SIMPLE Antibody…

arGEN-XBiotechnologyEuropeFinancialGenetics

US regenerative medicine market to increase at a CAGR of 15.8%

03-09-2013

The US regenerative medicine market has been forecast to increase at a compound annual growth rate (CAGR)…

BiotechnologyGeneticsMarkets & MarketingNorth America

Potential Duchenne drug expected to complete phase III trial this year

16-08-2013

Dutch biotech company Prosensa says it has made progress with its Duchenne treatments, with six exon…

drisapersenEuropeGeneticsGlaxoSmithKlinePharmaceuticalProsensaResearch

AHF claims victory over FDA in HIV prevention drug case

08-08-2013

The USA-based AIDS Healthcare Foundation (AHF) says it won a key legal victory in a push for drug safety…

Anti-viralsBiotechnologyGilead SciencesLegalNorth AmericaPharmaceuticalRegulationTruvada

Stem cell company ReNeuron gets backing from Welsh government

22-07-2013

UK-based stem cell company ReNeuron (AIM: RENE) will relocate to Wales after Arthurian Life Sciences,…

BiotechnologyEuropeFinancialGeneticsReNeuron

Genomics England's priorities announced on 65th anniversary of the UK's NHS

05-07-2013

The chief executive of the Association of the British Pharmaceutical Industry (ABPI) has welcomed the…

GeneticsPharmaceutical

Next generation sequencing market expected to grow to $2.7 billion by 2017

04-07-2013

The next generation sequencing (NGS) market has been forecast to increase at a compound annual growth…

BiotechnologyEuropeGeneticsIlluminaMarkets & MarketingNorth America

US Supreme Court issues mixed ruling on DNA patents

14-06-2013

The US Supreme Court yesterday (June 13) delivered its unanimous decision regarding the Association for…

BiotechnologyGeneticsLegalMyriad GeneticsNorth AmericaPatents

Genetics and genomics industry in the USA has a trillion dollar impact, new Battelle study shows

14-06-2013

A new Battelle study released this week by United for Medical Research illustrates the genetics and genomics…

BiotechnologyFinancialGeneticsNorth AmericaResearch

Treatment with old drug suramin corrects autism symptoms in mouse model

14-03-2013

Testing a new theory, researchers at the University of California, San Diego School of Medicine have…

GeneticsMetabolicsPharmaceuticalResearch

AHF demands FDA reversal on use of Gilead's HIV prevention pill for women

06-03-2013

Citing another failed clinical trial in women of the use of Gilead Sciences' (Nasdaq: GILD) AIDS drug…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationResearchTruvada

Ethris enters SNIM modified RNA alliance with Shire

07-01-2013

German biotech firm Ethris GmbH has initiated a research based alliance focused on the development and…

BiotechnologyEthris GmbHGeneticsLicensingPharmaceuticalResearchShire

New Zealand to fund Gilead's Atripla and Truvada

27-11-2012

New Zealand's Pharmaceutical Management Agency PHARMAC says that, effective December 1, it will fund…

Anti-viralsAsia-PacificAtriplaBiotechnologyFinancialGilead SciencesPharmaceuticalRegulationTruvada

Gilead HIV drugs Atripla and Truvada to be listed in New Zealand

13-11-2012

Following a consultation, New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval…

Anti-viralsAsia-PacificAtriplaBiotechnologyGilead SciencesPharmaceuticalPricingRegulationTruvada

1 to 25 of 39 results

Company Spotlight

Fibrotech

Fibrotech

Back to top